Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Euroasian Journal of Hepato-Gastroenterology|July 3, 2018
Liver Disease in SingaporeMark Muthiah, Chern H Chong, Seng G LimThe Lancet. Gastroenterology & Hepatology|December 20, 2019
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology CommissionShiv K Sarin, Manoj Kumar, Mohammed Eslam, et al.Journal of Clinical and Experimental Hepatology|December 11, 2023
NAFLD and NAFLD-related HCC in Asia: Burden and SurveillanceJia H Koh, Meng Wang, Hiroyuki Suzuki, et al.Cancer Science|June 3, 2009
Role of the miR-106b-25 microRNA cluster in hepatocellular carcinomaYang Li, Weiqi Tan, Thomas W L Neo, et al.The Medical Clinics of North America|March 31, 2023
The Past, Present, and Future of Noninvasive Test in Chronic Liver DiseasesDouglas Chee, Cheng Han Ng, Kai En Chan, et al.Diabetes Research and Clinical Practice|April 4, 2024
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease populationNicholas W S Chew, Xin Hui Pan, Bryan Chong, et al.Frontiers in Immunology|June 22, 2026
Hidradenitis suppurativa and psoriasis: shared immunological links with metabolic-associated steatotic liver diseaseWei Qiang Chng, Jake J Liew, Choon Fong Liew, et al.Antiviral Therapy|December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patientsKeyur Patel, Seng G Lim, Chow W Cheng, et al.Nature Medicine|May 7, 2025
Cardiac and liver impairment on multiorgan MRI and risk of major adverse cardiovascular and liver eventsEdward Jackson, Andrea Dennis, Naim Alkhouri, et al.Hepatology (Baltimore, Md.)|December 13, 2023
Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantationMohammad Shadab Siddiqui, Mark Muthiah, Sanjaya K Satapathy, et al.Pageof 13